Pharvaris NV expected to post a loss of 64 cents a share - Earnings Preview
Brief: Pharvaris Promotes Annick Deschoolmeester To Chief Human Resources Officer
Pharvaris NV reports results for the quarter ended in June - Earnings Summary
Brief: Pharvaris NV reports Q2 results
Pharvaris NV expected to post a loss of 56 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 56 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Minerva, Cano Health, United Maritime
Pharvaris drops as FDA places clinical hold on swelling disorder drug trials
U.S. STOCKS ON THE MOVE-Pinduoduo Inc, Signify Health Inc, Bruker Corp
Brief: Pharvaris Announces FDA Clinical Hold On PHA121 Clinical Trials In U.S.
Pharvaris NV expected to post a loss of 56 cents a share - Earnings Preview
Brief: Pharvaris Reports Q1 Loss Per Share Of EUR 0.48
Brief: Pharvaris Reports Fourth Quarter Results, Provides Business Highlights
Brief: Pharvaris NV Files For Mixed Shelf Of Up To $350 Million – SEC Filing
Brief: Pharvaris NV Announces Appointment Of Elisabeth Björk M.D. To The Board Of Directors
Pharvaris NV reports results for the quarter ended in September - Earnings Summary
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview